Activating mutations in CTNNB1, inactivating mutations in TP53, and activating mutations in telomerase reverse transcriptase (TERT) are the most frequently detected mutations in HCC [21,22,23,24,25,26]. This evidence concerns the gene TERT and hepatocellular carcinoma.